Burnham Institute for Medical Research (Burnham) today announced that Daniel P. Kelly, M.D. will assume the position of Scientific Director of Burnham at Lake Nona in Orlando, Florida. In that capacity he will guide the scientific direction of Burnham’s Orlando facility by forming several research programs related to diabetes, obesity, metabolism and heart disease. In addition, Dr. Kelly will be responsible for faculty recruitment for the Orlando site, which is situated in Lake Nona’s “medical city,” a newly developed science and technology park with several university and clinical partners.
“I was attracted by the excitement of building a unique world-class research effort focused on the immense problem of diabetes and its complications,” said Dr. Kelly. “The power of interdisciplinary research can be harnessed in a single institute by bringing together scientists across many different fields. I look forward to assembling a team that capitalizes on the current strengths of the Burnham organization, while adding talented new scientists that drive our research mission forward. Linking discovery science to health care delivery by working with our clinical partners in the context of the developing medical city will change the future of health care.”
Dr. Kelly will officially join Burnham on July 1, 2008. He is currently the Tobias and Hortense Lewin Professor, Director of the Center for Cardiovascular Research, and Chief of the Cardiovascular Division in the Department of Medicine at Washington University School of Medicine in St. Louis, Missouri. Dr. Kelly joined the Washington University School of Medicine faculty in 1989 after obtaining his M.D. from the University of Illinois College of Medicine in Chicago in 1982 and completing a medicine residency followed by Postdoctoral Fellowships in the Biological Chemistry and Clinical Cardiology departments at Washington University School of Medicine. He moved up the ranks from Instructor of Medicine to tenured Professor of Medicine, Molecular Biology and Pharmacology, and Pediatrics at Washington University.
Dr. Kelly’s scientific interests include fundamental and translational research in cellular energy metabolism relevant to common diseases such as heart failure and diabetes, especially diabetic heart disease. He is the author of more than 100 peer-reviewed original research papers focusing on these areas.
“We are proud that Dr. Kelly is joining the Burnham team to lead expansion of our medical research programs in Florida, and to launch a new research center devoted to diabetes and obesity research,” said John C. Reed, M.D., Ph.D., President and CEO, Professor and Donald Bren Presidential Chair. “Our organization and our collaborators will benefit significantly from Dr. Kelly’s scientific vision, impressive leadership qualities and strong track record of success in building world-class research programs.”